| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |